{ "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-12T08:39:12Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 21.1, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a094c4-288b-7882-a208-22567f2f44c2\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: chloropyramine\nSense to describe: (none recorded)\nDomain code: PHY.MAT\nAlso known as: (none)\n\n\nContext for this batch of 1001 things:\n# Batch 043: 1001 ", "usd": 0.0, "recall": true }, "codex": { "seconds": 74.4, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a094c4-289b-7881-905c-18fcb348f59d\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: chloropyramine\nRegistry id: vr.tr.chloropyramine\nPlane / domain: PHY / PHY.MAT\nRegistry definition: (none recorded)\nNames folded into this entry: (no" } }, "enrichment": { "pass": 3, "engine": "claude", "producedAt": "2026-10-06T12:00:00Z", "ingestedAt": "2026-10-06T08:51:29+00:00", "fields": [ "agent_conduct", "ethics", "failure_modes_and_hazards", "owners", "standards_and_regulation", "visual_identification" ] }, "gate": { "passed": true, "version": "1.0", "at": "2026-10-07T10:10:32+00:00", "evidence": [ "completeness 1.00", "sense: Wikidata description", "2 live sources", "review by codex: pass" ] } }, "metaModel": { "id": "THING-Q729863", "registryId": "vr.tr.chloropyramine", "name": "chloropyramine", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "PHY.MAT" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q729863/", "model": { "registry_id": "vr.tr.chloropyramine", "name": "chloropyramine", "purpose": "Enable an agent to identify chloropyramine, assess the identity and condition of a material containing it, and determine which handling, analytical or use decisions are supported by evidence.", "definition": "Chloropyramine is a synthetic ethylenediamine-class, first-generation histamine H1-receptor antagonist used as an antihistamine and commonly formulated as its hydrochloride salt.", "scope_statement": "This model owns the substance identity of chloropyramine under vr.tr.chloropyramine in PHY / PHY.MAT, its material attributes and evidence requirements, and its relationships to salts, samples and medicinal products.", "in_scope": [ "Molecular identity, structural identifiers and verified synonyms", "Distinction between chloropyramine free base and salt forms, particularly the hydrochloride", "Sample composition, assay basis, impurities and grade", "Physical properties, stability and storage conditions for the identified form", "Evidence connecting the substance to biological activity, hazards and permitted uses" ], "out_of_scope": [ "Finished medicines, their excipients, packaging and brand identities", "Patient diagnosis, prescribing and individualized dosing", "Manufacturing processes and production equipment", "Clinical trials and experimental protocols as independently managed activities", "Other antihistamines and chloropyramine metabolites as separate substance identities" ], "distinguishing_features": [ "The free-base identity has CAS 59-32-5, formula C16H20ClN3 and molar mass approximately 289.803 g/mol. [NIST Chemistry WebBook](https://webbook.nist.gov/cgi/cbook.cgi?ID=59-32-5)", "Structural identification must match a 4-chlorobenzyl group and a pyridin-2-yl group attached to the same nitrogen of an N',N'-dimethylethane-1,2-diamine framework; a similar drug name alone is insufficient. [NIST Chemistry WebBook](https://webbook.nist.gov/cgi/cbook.cgi?ID=59-32-5)", "Chloropyramine hydrochloride has CAS 6170-42-9 and formula C16H21Cl2N3; it must be recorded as a related salt form rather than assigned the free-base formula and mass. [Thermo Scientific Chemicals](https://www.fishersci.com/shop/products/chloropyramine-hydrochloride-thermo-scientific/AAJ6035003)", "A tablet, injection or other preparation containing chloropyramine is identified through its ingredient relationship and composition, rather than treated as pure chloropyramine." ], "characteristics": [ { "name": "Molecular identity", "kind": "category", "unit_or_values": "Verified structure, CAS number, InChI or SMILES, and identifier authority", "why_it_matters": "Prevents confusion with similarly named antihistamines and incorrectly mapped supplier records." }, { "name": "Chemical form", "kind": "category", "unit_or_values": "Free base; hydrochloride; other evidenced salt; unresolved, with counterion and stoichiometry", "why_it_matters": "Determines the applicable formula, mass basis and physical-property evidence." }, { "name": "Chloropyramine content", "kind": "measurement", "unit_or_values": "Mass fraction %, mg/g or mol/L, explicitly stated as free-base equivalent or identified salt and as-is or dry basis", "why_it_matters": "Makes assay results and quantities comparable without confusing salt mass with active-moiety mass." }, { "name": "Impurity profile", "kind": "measurement", "unit_or_values": "Individual and total impurities in %, mg/kg or method-specific units, with detection limits", "why_it_matters": "Supports judgments about degradation, contamination and fitness for a specified use." }, { "name": "Material grade", "kind": "category", "unit_or_values": "Analytical reference material; research reagent; pharmaceutical ingredient; other documented grade; unknown", "why_it_matters": "An identity match does not establish suitability for pharmaceutical or quantitative analytical use." }, { "name": "Physical state and thermal behavior", "kind": "state", "unit_or_values": "Observed phase and appearance at stated temperature and pressure; melting or decomposition interval in °C", "why_it_matters": "Helps detect material changes while preventing properties of one salt or solid form from being applied to another." }, { "name": "Solution behavior", "kind": "measurement", "unit_or_values": "Solubility in g/L or mol/L; pH; pKa when verified, with solvent, temperature and method", "why_it_matters": "Supports preparation and interpretation of solutions without assuming free base and hydrochloride behave identically." }, { "name": "Storage and release status", "kind": "state", "unit_or_values": "Within documented conditions; excursion pending assessment; released; quarantined; expired or beyond retest date", "why_it_matters": "Connects sample history to whether further use is supported." }, { "name": "Biological activity evidence", "kind": "relation", "unit_or_values": "Target or effect linked to substance form, assay, concentration, biological system and source", "why_it_matters": "Keeps molecular activity evidence distinct from clinical efficacy and authorized indications." }, { "name": "Hazard and regulatory applicability", "kind": "relation", "unit_or_values": "Dated SDS, applicable GHS classification, exposure-limit evidence and jurisdiction-specific use status", "why_it_matters": "Prevents classifications or permissions for one form, product or jurisdiction from being generalized." } ], "affordances": [ "Resolve a chloropyramine name or identifier against a verified molecular structure.", "Classify a supplied material as free base, hydrochloride, another evidenced form or an unresolved mixture.", "Convert a documented salt quantity to chloropyramine free-base equivalents when stoichiometry, assay and water content support the calculation.", "Compare an identified sample against analytical and purity requirements for a specified use.", "Select form-specific storage and handling requirements from applicable evidence.", "Flag unsupported transfers of activity, hazard or authorization claims between substance, salt and finished medicine." ], "agent_conduct": { "may": [ "Identify chloropyramine by name, identifiers and documented properties, citing sources.", "Report approved uses and warnings in a stated country from official product information.", "Check a material lot's certificate of analysis against its specification." ], "must_not": [ "Recommend it or a dose for a particular person, including a child.", "Advise that it is safe to drive after taking it.", "Advise on using it to sedate anyone without their knowledge.", "Supply it outside lawful pharmaceutical channels." ], "requires_human": [ "Any decision to give it to a patient, especially a child or older person.", "Releasing or destroying a material lot." ] }, "ethics": { "considerations": [ "First-generation antihistamines cause drowsiness that endangers people on the road and at work.", "Widely available medicines are easily misused to sedate others." ], "affected_parties": [ "Patients with allergies", "Other road users", "Carers of children and older people" ] }, "owners": { "steward": "The marketing authorization holder for each medicine; the national medicines regulator oversees it.", "master_systems": [ "National medicines registers" ] }, "visual_identification": [ "Identity rests on the label, batch record and certificate of analysis, not appearance.", "Usually supplied as its hydrochloride salt, which labels state." ], "failure_modes_and_hazards": [ "Drowsiness and slowed reactions.", "Additive sedation with alcohol and other sedatives.", "Anticholinergic effects in older people." ], "standards_and_regulation": [ "ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, International Council for Harmonisation." ], "what_it_is_for": [ "Chloropyramine is encountered as an antihistamine ingredient in medicines used for allergic symptoms in countries where it is authorised.", "It is also encountered in pharmaceutical quality control and analytical research, where distinguishing the parent compound from its hydrochloride salt matters." ] }, "sources": [ { "id": "wikidata", "title": "Wikidata item Q729863: chloropyramine", "url": "https://www.wikidata.org/wiki/Q729863", "url_status": "live", "what_it_supports": "identity and sense of the item", "checked_by": "wikidata-api" }, { "id": "wikipedia-en", "title": "Wikipedia: Chloropyramine", "url": "https://en.wikipedia.org/wiki/Chloropyramine", "url_status": "live", "what_it_supports": "general description of the item", "checked_by": "wikidata-api sitelink" } ], "structure": { "bundles": [ { "id": "chloropyramine-identity", "name": "Chloropyramine identity", "description": "Establish which molecular entity the registry entry denotes and how supplied forms relate to it.", "rationale": "Free-base identity, hydrochloride identity and product names can otherwise collapse into one misleading record.", "layers": [ { "id": "molecular-recognition", "name": "Molecular recognition", "description": "Recognize chloropyramine through structure and authority-backed identifiers.", "findings": [ { "id": "structure-before-name", "name": "Structure before name", "description": "Require agreement between the chloropyramine structure and its identifiers before accepting a synonym or supplier match.", "questions": [ { "text": "Which authoritative structure and identifiers define the chloropyramine entity represented by this record?", "kind": "definition", "id": "structure-before-name-q01" }, { "text": "Does the candidate name resolve to that structure, a salt, a finished product or a different antihistamine?", "kind": "boundary", "id": "structure-before-name-q02" } ] } ] }, { "id": "base-and-salts", "name": "Base and salts", "description": "Maintain explicit relationships between the parent substance and counterion-containing forms.", "findings": [ { "id": "hydrochloride-boundary", "name": "Hydrochloride boundary", "description": "Record hydrochloride stoichiometry and identifiers separately while retaining its relationship to the registered parent substance.", "questions": [ { "text": "Is the material free base or a verified salt, and what counterion stoichiometry and solvation state are supported?", "kind": "measurement", "id": "hydrochloride-boundary-q01" }, { "text": "Which registry or catalogue record owns that form, and how should it link to vr.tr.chloropyramine without duplicating the parent model?", "kind": "boundary", "id": "hydrochloride-boundary-q02" } ] } ] } ] }, { "id": "chloropyramine-material-quality", "name": "Chloropyramine material quality", "description": "Determine what a sample contains and whether its documentation supports a proposed use.", "rationale": "A correctly named material may still have an unsuitable assay basis, impurity profile or grade.", "layers": [ { "id": "identity-and-assay", "name": "Identity and assay", "description": "Connect analytical observations to the identified form and quantity of chloropyramine.", "findings": [ { "id": "assay-basis", "name": "Assay basis", "description": "Distinguish identity confirmation from quantitative content and state whether results describe salt mass or free-base equivalents.", "questions": [ { "text": "Which analytical methods and reference materials confirm chloropyramine identity in this sample?", "kind": "measurement", "id": "assay-basis-q01" }, { "text": "Is the reported content on an as-is, dried, anhydrous, salt-mass or free-base-equivalent basis?", "kind": "measurement", "id": "assay-basis-q02" } ] } ] }, { "id": "impurities-and-grade", "name": "Impurities and grade", "description": "Assess non-chloropyramine components and the evidence behind a grade designation.", "findings": [ { "id": "use-specific-quality", "name": "Use-specific quality", "description": "Require lot-specific evidence for water, residual solvents and relevant organic or inorganic impurities rather than treating a purity label as sufficient.", "questions": [ { "text": "Which impurities were measured, by which methods, and with what limits and unresolved peaks?", "kind": "measurement", "id": "use-specific-quality-q01" }, { "text": "Does the lot certificate and applicable specification support the proposed analytical, research or pharmaceutical use?", "kind": "action", "id": "use-specific-quality-q02" } ] } ] } ] }, { "id": "chloropyramine-physical-condition", "name": "Chloropyramine physical condition", "description": "Describe form-dependent properties and the sample changes that affect continued use.", "rationale": "Properties and storage claims must follow the actual base, salt or solution being assessed.", "layers": [ { "id": "phase-and-solution-properties", "name": "Phase and solution properties", "description": "Record thermal and solution measurements with their chemical form and experimental conditions.", "findings": [ { "id": "conditioned-property-values", "name": "Conditioned property values", "description": "Attach phase, thermal behavior and solubility observations to a verified material form rather than to the name chloropyramine alone.", "questions": [ { "text": "What phase and melting or decomposition behavior are documented for this form, at what pressure and by what method?", "kind": "measurement", "id": "conditioned-property-values-q01" }, { "text": "What solubility and solution pH are supported for the intended solvent, concentration and temperature?", "kind": "measurement", "id": "conditioned-property-values-q02" } ] } ] }, { "id": "stability-and-storage", "name": "Stability and storage", "description": "Evaluate storage history and evidence of chemical or physical change.", "findings": [ { "id": "continued-use-evidence", "name": "Continued-use evidence", "description": "Connect storage excursions and solution age to validated stability evidence and sample disposition.", "questions": [ { "text": "Which temperature, light, moisture and container conditions are supported for this chloropyramine form or solution?", "kind": "provenance", "id": "continued-use-evidence-q01" }, { "text": "Do storage history, retest date or analytical changes require reassessment before further use?", "kind": "action", "id": "continued-use-evidence-q02" } ] } ] } ] }, { "id": "chloropyramine-biological-evidence", "name": "Chloropyramine biological evidence", "description": "Organize evidence for chloropyramine activity without converting it into unsupported treatment claims.", "rationale": "An agent must distinguish receptor-level observations, experimental effects and medicinal uses.", "layers": [ { "id": "target-and-assay-context", "name": "Target and assay context", "description": "Identify what biological activity was measured and under which exposure conditions.", "findings": [ { "id": "histamine-h1-evidence", "name": "Histamine H1 evidence", "description": "Make histamine H1 activity an explicit research target and retain assay-specific evidence for any accepted pharmacological characterization.", "questions": [ { "text": "Which primary studies establish chloropyramine activity at histamine H1 receptors, and in which biological systems?", "kind": "provenance", "id": "histamine-h1-evidence-q01" }, { "text": "What endpoint, concentration basis, chemical form and comparator support each reported activity value?", "kind": "measurement", "id": "histamine-h1-evidence-q02" } ] } ] }, { "id": "effect-and-use-boundaries", "name": "Effect and use boundaries", "description": "Separate experimental observations from evidence applicable to medicinal products.", "findings": [ { "id": "claim-transfer-limits", "name": "Claim transfer limits", "description": "Keep evidence for additional targets, adverse effects and clinical outcomes attached to the studied system and exposure.", "questions": [ { "text": "Which reported effects have direct chloropyramine evidence rather than inference from another antihistamine or the drug class?", "kind": "provenance", "id": "claim-transfer-limits-q01" }, { "text": "Does a proposed claim belong to the substance model, an experimental study or a specific medicinal product and patient context?", "kind": "boundary", "id": "claim-transfer-limits-q02" } ] } ] } ] }, { "id": "chloropyramine-handling-and-status", "name": "Chloropyramine handling and status", "description": "Determine which hazard controls and use restrictions apply to the identified material.", "rationale": "Chemical handling classifications and medicinal authorization answer different questions and require different evidence.", "layers": [ { "id": "material-hazards", "name": "Material hazards", "description": "Identify applicable safety documentation for the actual form, concentration and supplier material.", "findings": [ { "id": "form-specific-safety", "name": "Form-specific safety", "description": "Use a dated, applicable SDS and exposure assessment; do not transfer hydrochloride classifications automatically to free base or mixtures.", "questions": [ { "text": "Which current SDS and GHS jurisdiction apply to this chloropyramine material and its concentration?", "kind": "provenance", "id": "form-specific-safety-q01" }, { "text": "Which exposure controls, disposal requirements and exposure limits are documented, and which remain unestablished?", "kind": "action", "id": "form-specific-safety-q02" } ] } ] }, { "id": "jurisdiction-and-use", "name": "Jurisdiction and use", "description": "Connect an intended activity to dated authority records and material qualification.", "findings": [ { "id": "authorized-use-evidence", "name": "Authorized-use evidence", "description": "Treat registry identifiers as identity evidence and seek separate evidence for pharmaceutical suitability and legal use.", "questions": [ { "text": "Which authority record establishes the relevant chloropyramine substance or product status in the intended jurisdiction and on what date?", "kind": "provenance", "id": "authorized-use-evidence-q01" }, { "text": "What additional qualification is required before this particular lot may be used for the proposed purpose?", "kind": "action", "id": "authorized-use-evidence-q02" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This is a recall-based description; no sources were consulted.", "Verify identifiers against authoritative records, keeping the free base and hydrochloride salt separate.", "Physical constants, purity specifications, GHS classifications and current national authorizations require verification for the specific chemical form or product." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of chloropyramine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Chloropyramine free base", "Chloropyramine hydrochloride" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of chloropyramine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "International Nonproprietary Name (INN)", "value_or_pattern": "chloropyramine", "note": "Names the active substance rather than a branded formulation." }, { "scheme": "CAS Registry Number", "value_or_pattern": "59-32-5", "note": "Identifies the free base; the hydrochloride salt has a separate registry identity." }, { "scheme": "WHO ATC classification", "value_or_pattern": "R06AC03", "note": "Classifies chloropyramine among substituted ethylenediamine antihistamines for systemic use." }, { "scheme": "Molecular formula", "value_or_pattern": "C16H20ClN3", "note": "Formula of the free base, excluding the additional hydrogen chloride in the hydrochloride salt." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of chloropyramine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Symptomatic treatment of allergic conditions, including urticaria and allergic rhinitis, where locally authorized.", "Use in oral medicinal products, commonly as chloropyramine hydrochloride." ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of chloropyramine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-measurements", "name": "Typical measurements", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "quantity": "Molar mass of the free base", "typical_range": "289.80", "unit": "g/mol" } ], "questions": [ { "id": "evidence-measurements-q01", "text": "Which of these typical measurements hold for the sense of chloropyramine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Sedation and impaired attention or psychomotor performance.", "Anticholinergic effects, including dry mouth, blurred vision, constipation and urinary retention.", "Increased impairment when combined with alcohol or other central nervous system depressants.", "Overdose can cause serious neurological and cardiovascular toxicity.", "Confusing free-base and hydrochloride quantities can produce errors in chemical characterization or formulation calculations." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of chloropyramine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Medicinal use is associated particularly with parts of Central and Eastern Europe and former Soviet countries.", "Marketing authorization, available formulations and prescription status differ by country." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of chloropyramine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "Chloropyramine hydrochloride", "difference": "The hydrochloride is a salt of chloropyramine with an additional chloride counterion; it has a different formula and molar mass from the free base." }, { "name": "Chlorphenamine", "difference": "A distinct first-generation H1 antihistamine in the alkylamine class, with different molecular connectivity and identifiers." }, { "name": "Chloropyramine medicinal product", "difference": "A finished product contains a specified dose and formulation of the substance together with excipients; it is not the chemical substance itself." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of chloropyramine this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Does the existing Vercy catalogue already contain an authoritative chloropyramine model, and how does the registry represent its hydrochloride form?", "Which verified PubChem, EC and other authority identifiers belong to the free base versus hydrochloride, and which apparent synonyms are only product names?", "Which reliable measurements establish form-specific melting or decomposition behavior, boiling behavior where meaningful, solubility, pKa and storage stability?", "Which primary studies and official product documents substantiate H1 activity, other biological effects and adverse-effect claims, and where are findings only class-based inferences?", "Which current specifications, GHS classifications, occupational exposure limits and jurisdiction-specific medicinal statuses apply to the intended material and use?" ], "statistics": { "bundles": 6, "layers": 11, "findings": 18, "questions": 28 } }